Start writing here...
On 11 December, the 2025 2degrees Auckland Business Awards ceremony was grandly held in Auckland.
As a flagship annual business event hosted by the Auckland Business Chamber, the Awards have accompanied New Zealand enterprises through 169 years of commercial development, witnessing the rise of countless industry pioneers.
This year, Unipharm was shortlisted for the Excellence in Strategy category in recognition of its clear and resilient strategic positioning, becoming the only health and wellness manufacturing company among all finalists.
The steady execution of a long-term strategy is the core driver of high-growth enterprises.
This award recognises organisations that are able to formulate and effectively implement long-term strategies, demonstrating clear objectives, sustained investment, and high-quality growth. The judging panel places particular emphasis on the maturity of strategic planning, execution cadence, outcome measurement frameworks, and organisational alignment.
Quality as the foundation: building a manufacturing system trusted globally
Unipharm has always regarded product quality as the lifeline of its business. Through rigorous quality control systems, high-standard manufacturing processes, and continuous investment in international quality frameworks, the company has earned stable and long-term trust from global clients.
R&D driving the future: building sustainable innovation capability
As one of New Zealand’s leading health and wellness manufacturers, Unipharm continues to invest in research facilities, talent, and technology platforms, consistently delivering innovative dosage forms and higher value-added health solutions. R&D capability has become a critical engine supporting the company’s long-term growth.
Strategic planning guiding growth: building a scalable and replicable global pathway
In response to a rapidly changing global market, Unipharm has achieved continuous breakthroughs in international expansion, capacity development, and supply chain optimisation through systematic eight-year planning, multi-market布局, and prudent operational strategies.
Sailing towards a longer-term future together
Being shortlisted alongside companies from diverse industries and of varying scales is particularly meaningful for Unipharm—it not only reflects official recognition of our achievements, but also signals that the value of the health and wellness manufacturing sector is becoming increasingly visible within New Zealand’s broader business landscape.
Looking ahead, Unipharm will continue to steer by strategy, anchor in R&D, and root itself in quality.
We remain committed to advancing New Zealand’s health manufacturing sector to higher standards and, through steady progress, creating enduring value for the industry, our clients, and the market.
